Biogen, Shire called out by FDA for ‘gaming’ generic access rule

The FDA on Thursday released a list of more than three dozen drugmakers that it said have been accused of using “gaming tactics" to block other firms from developing generic versions of their products. Among those named: Biogen Inc. and Shire plc, two of the largest drug companies in Massachusetts. The FDA’s decision to publish the list is part of a broader effort by the Trump administration to drive dow n the cost of brand name drugs. The agency identified 39 companies that have been the subject…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news